Hematology - European Medical Journal

Continue

Hematology

Filter
2 Mins
25 Jul 2024

TET2 Mutations Affect Stem Cell Response to Immune Stress

Understanding how loss of function mutation of TET2 in haematopoietic stem cells (HSC) changes their response to stress is crucial to…
2 Mins
25 Jul 2024

KMT2A-MLLT3-Induced Leukaemia Changes During Ontogenic Stages

The KMT2A-MLLT3 (also known as MLL-AF9) fusion is associated with acute lymphoid leukaemia (ALL), acute myeloid leukaemia (AML), and mixed…
2 Mins
25 Jul 2024

A-HIPI Prognostic Index in Turkish Patients with Hodgkin Lymphoma: Single-Center Retrospective Study

The historical International Prognostic Score (IPS-7), which was developed with patient data from the 1980s, and the more recent IPS-3…
1 Mins
25 Jul 2024

Five-Year Outcomes of CD19/CD22 CAR-T Therapy in Post-Allo B-ALL Relapse

The authors have previously reported their Phase I clinical trial regarding a combination treatment of CD19- and CD22-specific chimeric…
2 Mins
20 Jul 2023

RAS-ERK Pathway Genes Mutations in the Lesions from Various Tumour Loci in Multiple Myeloma

There is a trend towards higher frequency of high-risk cytogenetic aberrations in patients with NRAS gene mutations compared to patients with KRAS gene mutations. Read more.
2 Mins
20 Jul 2023

UBA1 Non-M41 Variants Are More Aggressive than UBA1 M41 Variants in Their Haematological Manifestations

The ongoing large-scale screen of non-M41 variants in patients suspected of HMs continues to detect both recurrent and novel non-M41 variants. The patients harbouring non-M41 variants are rare but may be more malignant.
1 Mins
20 Jul 2023

Introducing the Concept of Patient Blood Management and Haemovigilance in Government Sector Hospitals of Sindh, Pakistan

Patient blood management encompasses all aspects of the transfusion decision-making process, beginning with the initial patient evaluation and continuing through clinical management.
6 Mins
20 Jul 2023

EHA 2023 Abstract Highlights

Classical Hodgkin lymphoma, acute promyelocytic leukaemia, post-transplant relapse, massive transfusion, and many more essential topics in haematology were explored in several unique and insightful abstracts presented at the European Hematology Association (EHA) 2023 Congress.